Discussion: An estimate of the science-wise false discovery rate and applications to top medical journals by Jager and Leek

Biostatistics

Volumn 15, Issue 1, 2014, Pages 13-16

  Benjamini, Yoav ^a   Hechtlinger, Yotam ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; LABORATORY DIAGNOSIS; MEDICAL RESEARCH; NOTE; PUBLICATION; STANDARD; STATISTICAL ANALYSIS;

BIOMEDICAL RESEARCH; DATA INTERPRETATION, STATISTICAL; FALSE POSITIVE REACTIONS; HUMANS; PUBLICATIONS;

EID: 84890506929     PISSN: 14654644     EISSN: 14684357     Source Type: Journal    
DOI: 10.1093/biostatistics/kxt032     Document Type: Note

References (7)

1. ABRAMOVICH, F., BENJAMINI, Y., DONOHO, D. AND JOHNSTONE, I. M. (2006). Adapting to unknown sparsity by controlling the false discovery rate. The Annals of Statistics 34, 584-653. (Pubitemid 44091387)
2. BENJAMINI, Y. (2010). Simultaneous and selective inference: current successes and future challenges. Biometrical Journal 52(6), 708-721, doi:10.1002/bimj.200900299.
3. BENJAMINI, Y. AND YEKUTIELI, Y. (2005). False discovery rate controlling confidence intervals for selected parameters. Journal of the American Statistical Association 100, 71-80.
4. COHEN, R. (2013). Hierarchical weighted methods that control the false discovery rate and their use in medical research. Tel Aviv University, [PhD. Thesis].
5. FLETCHER, S. W. AND COLDITZ, G. A. (2002). Failure of estrogen plus progestin therapy for prevention. Journal of the American Medical Association, 288, 366-369.
6. KAPLAN (2008). Current Dilemma in Drug Development Increasing Failure Rate of investigational Drugs in Phase 3. http://powershow.com/view1/183eb3- YjZmY/Current Dilemma in Drug Development Increasing Failure Rate of Investigational Drugs in Phase 3 Clin powerpoint ppt presentatio.
7. SORIÇ, B. (1989). Statistical "discoveries" and effect size estimation. Journal of the American Statistical Association 84, 608-610.